1. Penile and Testicular Cancer: What's New in 2006?
Eric Lechevallier, Nicolas Mottet, Richard Berges 
European Urology Supplements 
Volume 6, Issue 4, Pages (March 2007)
DOI: /j.eursup
Copyright © 2007 European Association of Urology Terms and Conditions

2. Fig. 1
Relapse is statistically significantly less frequent in patients with stage I seminomal germ cell tumours treated with adjuvant carboplatin than in those managed with surveillance [15].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

3. Fig. 2
Relapse is statistically significantly less frequent in patients with stage I non–seminomatous germ-cell tumours (NSGCT) treated with one course of adjuvant cisplatin, etoposide, and bleomycin (BEP) than in those treated with adjuvant retroperitoneal lymph node dissection (RPLND) [16].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

4. Fig. 3
The complete response rate is statistically significantly higher in poor-risk testicular cancer patients with a slow decline of serum markers receiving high-dose chemotherapy compared with those receiving standard-dose chemotherapy [21].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

5. Fig. 4
The presence of disease outside the modified template after a postchemotherapy retroperitoneal lymph node dissection (RPLND) is associated with a decreased disease-free survival [27].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions

6. Fig. 5
Non–seminoma germ cell tumour (NSGCT) patients who underwent a postchemotherapy retroperitoneal lymph node dissection (RPLND) for residual disease and who have two or more risk factors for relapse have a lower progression-free probability than NSGCT patients who have one or no risk factor for relapse (p<0.001) [29].
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2007 European Association of Urology Terms and Conditions